Tech Transfer Central
University-Industry Engagement Advisor

Job Listings


Licensing and Commercialization Professional at Princess Margaret Cancer Centre

 

Position: Licensing and Commercialization Professional, Princess Margaret Cancer Centre (2 positions)
Site: MaRS – Heritage Building
Department: Commercialization at UHN
Reports to: Director – Commercialization at UHN
Salary range: $92,996 – 116,240 (Commensurate with experience and consistent with UHN Compensation Policy)
Status: Permanent Full-time

University Health Network (UHN) is looking for an experienced professional to fill the key role of Licensing & Commercialization Professional in our Commercialization at UHN department.

Transforming lives and communities through excellence in care, discovery and learning.

University Health Network, where “above all else the needs of patients come first”, encompasses Toronto Rehabilitation Institute, Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre and the Michener Institute of Education at UHN. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of groundbreaking firsts and a purpose of “Transforming lives and communities through excellence in care, discovery and learning”, the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,600 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.

University Health Network (UHN) is a research hospital affiliated with the University of Toronto and a member of the Toronto Academic Health Science Network. The scope of research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. Research across UHN’s seven research institutes spans the full spectrum of diseases and disciplines, including cancer, cardiovascular sciences, transplantation, neural and sensory sciences, musculoskeletal health, rehabilitation sciences, and community and population health. Find out about our purpose, values and principles here.

UHN considers innovation and the commercial development of intellectual property (IP) to be integral to its purpose of transforming lives and communities through excellence in care, discovery and learning. Technologies discovered and developed at UHN have formed the basis for many global products and services including pharmaceuticals, biologicals, devices, and diagnostics and represent the foundational IP of spin-out companies contributing billions to the biotech economy in Canada and beyond (i.e., Trillium Therapeutics, Northern Biologics, AvroBio, BlueRock Therapeutics, and Acumyn). The basic research initiatives and translational expertise of UHN’s research and clinical investigators generate a large and growing portfolio of opportunities for corporate partnerships and new ventures.

Enabling and leading commercialization partnerships for a healthier world, the team at Commercialization at UHN works on accelerating the world-class research and innovation at UHN into medical products, devices and therapies that improve care for patients around the world. As the leading commercialization institution in Canada and one of the most successful research commercialization facilities in North America, we aspire to maximize the impact of commercialization for patient health, aligned with UHN’s purpose, values and principles. Located at the heart of Toronto’s MaRS Discovery District, Commercialization at UHN professionals manage the intellectual property developed by research scientists and clinicians and work with industry partners and investors to maximize the value of the technology to improve world heath and sustain medical research. Commercialization at UHN consolidates separate business functions (licensing, research agreement contracting, patenting, marketing, alliance management, accelerator fund management, commercial analysis and start-up company formation) into a unified office to facilitate interactions with corporate partners, and embeds dedicated Licensing Professional staff within the UHN Research Institutes to coordinate activities between Commercialization at UHN and these centres of innovation.

The role of Licensing & Commercialization Professional for the Princess Margaret Cancer Centre (PM) requires a dynamic, creative, business development professional with skills in relationship management and academic credentials or experience in the field of oncology.

The Professional will work collaboratively to develop and implement strategies to maximize the commercial success of research being conducted at PM and will foster and leverage internal and external relationships to facilitate the identification, development, commercialization and transfer to practical use of institute- or program-specific inventions, assets and technologies.

The Professional will maintain an overview of the various research activities and programs, assess the market potential of specific inventions, develop IP and marketing strategies for each, market to and engage in discussions with pharmaceutical and biotechnology companies, and negotiate research agreements and term-sheets with external parties. He or she will take the lead in all aspects of revenue generation including evaluation, protection, marketing, licensing, and new company creation. In addition, the Professional will work to source seed and venture funding, from initial contact with academic inventors to successful commercialization, in collaboration with other members of UHN’s Commercialization office.

Responsibilities include: proactively initiating, developing and maintaining strong relationships with the scientific research and clinical community; being an ongoing point of contact for researchers for the processing of new intellectual property as well as the development of commercialization and research support agreements; assisting inventors in identifying and assessing potential scientific research that could lead to commercialization outcomes; participating with inventors in securing commercialization funds to further develop IP; proactively pursuing relationships with potential licensing and commercialization partners; participating in direct marketing of UHN opportunities including pitching to targeted organizations; negotiating all aspects of research, service, licensing and other contracts; monitoring licensees to ensure companies are complying with financial and other major diligence in agreements; working collaboratively as part of a team environment focused on IP stewardship to ensure successful implementation of major team initiatives; serving as an enthusiastic ambassador of Commercialization and the commercialization process

Qualifications

  • Completion of a Master’s degree in Life Sciences or Medical Technology or equivalent experience required; PhD and/or MBA highly preferred
  •  Minimum of 7 years of relevant business experience or equivalent
  •  Industry experience and/or scientific background in the field of oncology is required
  •  Experience working in pharmaceutical or biotech business development, technology transfer, venture capital or related environment preferred; excellent knowledge of biotechnology and pharmaceutical markets required
  •  Experience in the negotiation of research support, licensing and/or partnership deals is required
  •  Very good capacity for understanding and evaluating detailed legal agreements and knowledge of licensing practice required
  •  Good knowledge of patent practice required; knowledge of internet patent and other database searches would be an asset
  •  Experience launching and leading start-up biotech companies (including sourcing seed and venture capital funding and divestments) would be an asset
  •  Must demonstrate outstanding communication and collaboration skills, and be able to represent the values of the Commercialization team including the provision of excellent client service
  •  Ability to multi-task and prioritize while working under pressure with tight deadlines is required
  •  Self-starter with demonstrated history of taking initiatives
  •  Strong presentation skills required
  •  Ability and comfort communicating to a range of stakeholders, from researchers to CEO’s, from a business and science perspective                                                               

Vaccines (COVID and others) are a requirement of the job unless you have an exemption on a medical ground pursuant to the Ontario Human Rights Code.

If you are interested in making your contribution at UHN, please apply on-line. You will be asked to copy and paste as well as attach your resume and cover letter. You will also be required to complete some initial screening questions.

Posted Date: November 11, 2021                    Closing Date: December 9, 2021

For current UHN employees, only those who have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN’s attendance management program, and possess all the required experience and qualifications should apply.

UHN thanks all applicants, however, only those selected for an interview will be contacted.

Click here for more details or to apply >>